One Stock to Buy and Two to Sell Amid Downbeat Forecasts: Unity, Integra LifeSciences, and Nicolet Bankshares

Unity (U) faces challenges with 6% declines in billings over the past year, high customer acquisition costs, and a suboptimal cost structure. Integra LifeSciences (IART) has no organic revenue growth, decreased efficiency, and a shrinking free cash flow margin. Nicolet Bankshares (NIC) is a regional bank holding company with a consensus price target of $147.40, offering a 6.6% implied return.